These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 15528253

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Evidence for autocrine actions of neuromedin B and gastrin-releasing peptide in non-small cell lung cancer.
    Siegfried JM, Krishnamachary N, Gaither Davis A, Gubish C, Hunt JD, Shriver SP.
    Pulm Pharmacol Ther; 1999; 12(5):291-302. PubMed ID: 10545285
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Neuromedin B is present in lung cancer cell lines.
    Giaccone G, Battey J, Gazdar AF, Oie H, Draoui M, Moody TW.
    Cancer Res; 1992 May 01; 52(9 Suppl):2732s-2736s. PubMed ID: 1563005
    [Abstract] [Full Text] [Related]

  • 5. Differential expression of IGF-binding protein-3 in normal and malignant colon and its influence on apoptosis.
    Jenkins PJ, Khalaf S, Ogunkolade W, McCarthy K, David T, Hands RE, Davies D, Bustin SA.
    Endocr Relat Cancer; 2005 Dec 01; 12(4):891-901. PubMed ID: 16322329
    [Abstract] [Full Text] [Related]

  • 6. Gastrin-releasing peptide is a mitogen and a morphogen in murine colon cancer.
    Carroll RE, Matkowskyj KA, Tretiakova MS, Battey JF, Benya RV.
    Cell Growth Differ; 2000 Jul 01; 11(7):385-93. PubMed ID: 10939592
    [Abstract] [Full Text] [Related]

  • 7. Neuromedin B stimulates proliferation of mouse chondrogenic cell line ATDC5.
    Saito H, Ikeda R, Inoue K, Nagata S, Kitamura K, Minamino N, Kangawa K, Miyata A.
    Peptides; 2012 Aug 01; 36(2):299-302. PubMed ID: 22652580
    [Abstract] [Full Text] [Related]

  • 8. Increased frequency of gastrin-releasing peptide receptor gene mutations during colon-adenocarcinoma progression.
    Glover SC, Tretiakova MS, Carroll RE, Benya RV.
    Mol Carcinog; 2003 May 01; 37(1):5-15. PubMed ID: 12720295
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Discovery of high affinity bombesin receptor subtype 3 agonists.
    Wu JM, Nitecki DE, Biancalana S, Feldman RI.
    Mol Pharmacol; 1996 Nov 01; 50(5):1355-63. PubMed ID: 8913368
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparative pharmacology of the nonpeptide neuromedin B receptor antagonist PD 168368.
    Ryan RR, Katsuno T, Mantey SA, Pradhan TK, Weber HC, Coy DH, Battey JF, Jensen RT.
    J Pharmacol Exp Ther; 1999 Sep 01; 290(3):1202-11. PubMed ID: 10454496
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Bombesin stimulates adhesion, spreading, lamellipodia formation, and proliferation in the human colon carcinoma Isreco1 cell line.
    Saurin JC, Némoz-Gaillard E, Sordat B, Cuber JC, Coy DH, Abello J, Chayvialle JA.
    Cancer Res; 1999 Feb 15; 59(4):962-7. PubMed ID: 10029091
    [Abstract] [Full Text] [Related]

  • 18. Expression and characterization of cloned human bombesin receptors.
    Benya RV, Kusui T, Pradhan TK, Battey JF, Jensen RT.
    Mol Pharmacol; 1995 Jan 15; 47(1):10-20. PubMed ID: 7838118
    [Abstract] [Full Text] [Related]

  • 19. Expression of neuromedin B in adipose tissue and its regulation by changes in energy balance.
    Hoggard N, Bashir S, Cruickshank M, Miller JD, Speakman JR.
    J Mol Endocrinol; 2007 Sep 15; 39(3):199-210. PubMed ID: 17766645
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.